BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Laco F, Low JL, Seow J, Woo TL, Zhong Q, Seayad J, Liu Z, Wei H, Reuveny S, Elliott DA, Chai CL, Oh SK. Cardiomyocyte differentiation of pluripotent stem cells with SB203580 analogues correlates with Wnt pathway CK1 inhibition independent of p38 MAPK signaling. J Mol Cell Cardiol 2015;80:56-70. [PMID: 25528965 DOI: 10.1016/j.yjmcc.2014.12.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Maphis N, Jiang S, Xu G, Kokiko-Cochran ON, Roy SM, Van Eldik LJ, Watterson DM, Lamb BT, Bhaskar K. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology. Alzheimers Res Ther 2016;8:54. [PMID: 27974048 DOI: 10.1186/s13195-016-0221-y] [Cited by in Crossref: 50] [Cited by in F6Publishing: 51] [Article Influence: 10.0] [Reference Citation Analysis]
2 Hao W, Shi S, Zhou S, Wang X, Nie S. Aspirin inhibits growth and enhances cardiomyocyte differentiation of bone marrow mesenchymal stem cells. Eur J Pharmacol 2018;827:198-207. [PMID: 29551657 DOI: 10.1016/j.ejphar.2018.03.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
3 Zhang Z, Wang H, Yu H, Xiong Y, Zhang H, Ji L, Liu H. Synthesis, characterization and in vitro and in vivo photodynamic activities of a gallium( iii ) tris(ethoxycarbonyl)corrole. Dalton Trans 2017;46:9481-90. [DOI: 10.1039/c7dt00992e] [Cited by in Crossref: 26] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
4 Schade D, Plowright AT. Medicinal Chemistry Approaches to Heart Regeneration. J Med Chem 2015;58:9451-79. [DOI: 10.1021/acs.jmedchem.5b00446] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Kempf H, Zweigerdt R. Scalable Cardiac Differentiation of Pluripotent Stem Cells Using Specific Growth Factors and Small Molecules. Adv Biochem Eng Biotechnol 2018;163:39-69. [PMID: 29071404 DOI: 10.1007/10_2017_30] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Laco F, Woo TL, Zhong Q, Szmyd R, Ting S, Khan FJ, Chai CLL, Reuveny S, Chen A, Oh S. Unraveling the Inconsistencies of Cardiac Differentiation Efficiency Induced by the GSK3β Inhibitor CHIR99021 in Human Pluripotent Stem Cells. Stem Cell Reports 2018;10:1851-66. [PMID: 29706502 DOI: 10.1016/j.stemcr.2018.03.023] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 13.3] [Reference Citation Analysis]
7 Li XL, Zeng D, Chen Y, Ding L, Li WJ, Wei T, Ou DB, Yan S, Wang B, Zheng QS. Role of alpha- and beta-adrenergic receptors in cardiomyocyte differentiation from murine-induced pluripotent stem cells. Cell Prolif 2017;50. [PMID: 27790820 DOI: 10.1111/cpr.12310] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
8 Myrianthopoulos V, Lozach O, Zareifi D, Alexopoulos L, Meijer L, Gorgoulis VG, Mikros E. Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance. Int J Mol Sci 2017;18:E2102. [PMID: 28984824 DOI: 10.3390/ijms18102102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
9 Giancotti V, Bergamin N, Cataldi P, Rizzi C. Epigenetic Contribution of High-Mobility Group A Proteins to Stem Cell Properties. Int J Cell Biol 2018;2018:3698078. [PMID: 29853899 DOI: 10.1155/2018/3698078] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
10 Salem T, Frankman Z, Churko J. Tissue engineering techniques for iPSC derived three-dimensional cardiac constructs. Tissue Eng Part B Rev 2021. [PMID: 34476988 DOI: 10.1089/ten.TEB.2021.0088] [Reference Citation Analysis]
11 Jin G, Palecek SP. Inductive factors for generation of pluripotent stem cell-derived cardiomyocytes. Engineering Strategies for Regenerative Medicine. Elsevier; 2020. pp. 177-242. [DOI: 10.1016/b978-0-12-816221-7.00006-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Wang Y, Yi N, Hu Y, Zhou X, Jiang H, Lin Q, Chen R, Liu H, Gu Y, Tong C, Lu M, Zhang J, Zhang B, Peng L, Li L. Molecular Signatures and Networks of Cardiomyocyte Differentiation in Humans and Mice. Mol Ther Nucleic Acids 2020;21:696-711. [PMID: 32769060 DOI: 10.1016/j.omtn.2020.07.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Foulquier S, Daskalopoulos EP, Lluri G, Hermans KCM, Deb A, Blankesteijn WM. WNT Signaling in Cardiac and Vascular Disease. Pharmacol Rev 2018;70:68-141. [PMID: 29247129 DOI: 10.1124/pr.117.013896] [Cited by in Crossref: 113] [Cited by in F6Publishing: 112] [Article Influence: 37.7] [Reference Citation Analysis]
14 Zhong Q, Laco F, Liao MC, Woo TL, Oh SKW, Chai CLL. Influencing the Fate of Cardiac and Neural Stem Cell Differentiation Using Small Molecule Inhibitors of ALK5. Stem Cells Transl Med 2018;7:709-20. [PMID: 30063296 DOI: 10.1002/sctm.17-0246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Riehl BD, Donahue HJ, Lim JY. Fluid Flow Control of Stem Cells With Investigation of Mechanotransduction Pathways. Biology and Engineering of Stem Cell Niches. Elsevier; 2017. pp. 257-72. [DOI: 10.1016/b978-0-12-802734-9.00017-2] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
16 Gui ZP, Hu Y, Zhou YN, Lin KL, Xu YJ. Effect of quercetin on chondrocyte phenotype and extracellular matrix expression. Chin J Nat Med 2020;18:922-33. [PMID: 33357723 DOI: 10.1016/S1875-5364(20)60036-X] [Reference Citation Analysis]